The Board of Directors of Guiyang Xintian Pharmaceutical Co.,Ltd. has authorized a Buyback Plan on December 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.59 CNY | +3.49% |
|
-2.94% | -31.06% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.06% | 26Cr | |
+8.29% | 7.22TCr | |
+14.98% | 914.1Cr | |
-23.31% | 433.23Cr | |
+15.70% | 427.89Cr | |
+32.83% | 415.25Cr | |
+9.96% | 219.31Cr | |
-33.37% | 197.84Cr | |
+9.30% | 197.5Cr | |
-46.20% | 167.89Cr |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.